4597 — Solasia Pharma KK Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Solasia Pharma KK, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,310	454	559	1,092	617
Cost of Revenue
Gross Profit	1,245	245	374	662	337
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,072	4,570	2,978	3,562	1,756
Operating Profit	-1,762	-4,116	-2,419	-2,470	-1,139
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,797	-4,159	-2,442	-2,492	-1,135
Provision for Income Taxes
Net Income After Taxes	-1,867	-4,127	-2,477	-2,548	-1,113
Net Income Before Extraordinary Items
Net Income	-1,867	-4,127	-2,477	-2,548	-1,113
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,867	-4,127	-2,478	-2,548	-1,112
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-17.7	-30.7	-19	-18.1	-6.61
Dividends per Share